
GLP-1, or glucagon-like peptide-1 drugs, are a synthetic version of the body’s naturally occurring hormone that reduces appetite and slows down the rate at which food leaves the stomach. Originally developed to treat diabetes, GLP-1s’ popularity has skyrocketed because of their use for weight loss. In 2023, GLP-1s alone accounted for nearly 7% of the Read More

Financial savings arise for U.S. employers using captives to manage their health benefit plans. Jim Hoitt of Berkley Accident and Health explains how self-funded healthcare plans are better for employers than fully insured commercial health plans. More than 10 years ago, there was emerging interest among U.S. employers in a new concept: using group captives Read More